Aquestive Therapeutics, Inc. (AQST) SEC filings
AQST SEC filings moved a median of -1.49% by the close. AQST SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the AQST overview →
92 measured AQST SEC filing events.
Where these AQST SEC filings landedvs 89 measured AQST SEC filing reactions
| Middle 50% of AQST SEC filing reactions | -4.33% to +0.98% |
|---|---|
| Median reaction (to close) | -1.49% |
| Measured reactions | 89 |
Point-in-time · zero look-ahead
Half of the 89 AQST SEC filing events with a measured close landed between -4.33% and +0.98%; 33% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Aquestive Therapeutics, For: Oct 15 | SEC filing · Form 8-K | -0.86% | -12.88% | |
| Form 8-K Aquestive Therapeutics, For: Oct 13 | SEC filing · Form 8-K | -0.88% | -1.07% | |
| Form 8-K Aquestive Therapeutics, For: Sep 29 | SEC filing · Form 8-K | +0.21% | -0.64% | |
| Form 8-K Aquestive Therapeutics, For: Sep 23 | SEC filing · Form 8-K | +0.21% | -2.90% | |
| Form 8-K Aquestive Therapeutics, For: Sep 14 | SEC filing · Form 8-K | -1.20% | -6.80% | |
| Form 10-Q Aquestive Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +4.49% | +0.47% | |
| Form 8-K Aquestive Therapeutics, For: Aug 11 | SEC filing · Form 8-K | +4.49% | +0.47% | |
| Form 8-K Aquestive Therapeutics, For: Aug 10 | SEC filing · Form 8-K | +0.69% | — | |
| Form EFFECT Aquestive Therapeutics, | SEC filing · Form EFFECT | +0.58% | -1.85% | |
| Form S-3 Aquestive Therapeutics, | SEC filing · Form S-3 | -1.72% | -4.59% | |
| Form 8-K Aquestive Therapeutics, For: Jun 10 | SEC filing · Form 8-K | -0.50% | +4.99% | |
| Form 10-Q Aquestive Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -2.00% | -0.42% | |
| Form 8-K Aquestive Therapeutics, For: May 12 | SEC filing · Form 8-K | -2.00% | -0.42% | |
| Form ARS Aquestive Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.49% | +0.98% | |
| Form DEF 14A Aquestive Therapeutics, For: Jun 10 | SEC filing · Form DEF | +0.49% | +0.98% | |
| Form DEFA14A Aquestive Therapeutics, | SEC filing · Form DEFA14A | +0.49% | +0.98% | |
| Form 8-K Aquestive Therapeutics, For: Mar 30 | SEC filing · Form 8-K | -0.75% | +1.00% | |
| Form 8-K Aquestive Therapeutics, For: Mar 16 | SEC filing · Form 8-K | -0.74% | -1.49% | |
| Form 10-K Aquestive Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +3.99% | +0.00% | |
| Form 8-K Aquestive Therapeutics, For: Mar 03 | SEC filing · Form 8-K | +3.99% | +0.00% | |
| Form S-8 Aquestive Therapeutics, | SEC filing · Form S-8 | +3.99% | +0.00% | |
| Form 8-K Aquestive Therapeutics, For: Feb 26 | SEC filing · Form 8-K | -1.69% | -0.96% | |
| Form 8-K Aquestive Therapeutics, For: Jan 30 | SEC filing · Form 8-K | +2.51% | +2.76% | |
| Form S-8 Aquestive Therapeutics, | SEC filing · Form S-8 | +0.30% | -3.27% | |
| Form 8-K Aquestive Therapeutics, For: Jan 09 | SEC filing · Form 8-K | -3.54% | -1.26% | |
| Form 8-K Aquestive Therapeutics, For: Nov 06 | SEC filing · Form 8-K | -3.90% | -5.77% | |
| Form 10-Q Aquestive Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.65% | -5.40% | |
| Form 8-K Aquestive Therapeutics, For: Nov 05 | SEC filing · Form 8-K | +0.65% | -5.40% | |
| Form 8-K Aquestive Therapeutics, For: Oct 08 | SEC filing · Form 8-K | +1.32% | +2.65% | |
| Form 8-K Aquestive Therapeutics, For: Oct 01 | SEC filing · Form 8-K | -0.18% | +5.19% | |
| Form 8-K Aquestive Therapeutics, For: Sep 08 | SEC filing · Form 8-K | -1.82% | -8.91% | |
| Form 8-K Aquestive Therapeutics, For: Sep 04 | SEC filing · Form 8-K | +10.61% | +19.34% | |
| Form 8-K Aquestive Therapeutics, For: Aug 14 | SEC filing · Form 8-K | -0.24% | -1.44% | |
| Form 8-K Aquestive Therapeutics, For: Aug 13 | SEC filing · Form 8-K | -3.90% | +2.75% | |
| Form 10-Q Aquestive Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | — | |
| Form 8-K Aquestive Therapeutics, For: Aug 11 | SEC filing · Form 8-K | +0.00% | — | |
| Form 8-K Aquestive Therapeutics, For: Jul 15 | SEC filing · Form 8-K | +0.00% | -0.49% | |
| Form 8-K Aquestive Therapeutics, For: Jun 13 | SEC filing · Form 8-K | -5.40% | -1.94% | |
| Form 8-K Aquestive Therapeutics, For: Jun 11 | SEC filing · Form 8-K | +0.74% | -1.49% | |
| Form 8-K Aquestive Therapeutics, For: Jun 02 | SEC filing · Form 8-K | -1.78% | +13.17% | |
| Form 10-Q Aquestive Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.96% | -10.20% | |
| Form 8-K Aquestive Therapeutics, For: May 12 | SEC filing · Form 8-K | -1.96% | -10.20% | |
| Form ARS Aquestive Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.69% | -1.74% | |
| Form DEF 14A Aquestive Therapeutics, For: Jun 11 | SEC filing · Form DEF | +0.69% | -1.74% | |
| Form DEFA14A Aquestive Therapeutics, | SEC filing · Form DEFA14A | +0.69% | -1.74% | |
| Form 8-K Aquestive Therapeutics, For: Apr 01 | SEC filing · Form 8-K | -3.23% | -2.72% | |
| Form 8-K Aquestive Therapeutics, For: Mar 10 | SEC filing · Form 8-K | -0.77% | -2.68% | |
| Form 10-K Aquestive Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +5.58% | +4.88% | |
| Form 8-K Aquestive Therapeutics, For: Mar 05 | SEC filing · Form 8-K | +5.58% | +4.88% | |
| Form 8-K Aquestive Therapeutics, For: Feb 12 | SEC filing · Form 8-K | +0.85% | +15.31% | |
| Form S-8 Aquestive Therapeutics, | SEC filing · Form S-8 | +0.00% | -2.61% | |
| Form 8-K Aquestive Therapeutics, For: Jan 13 | SEC filing · Form 8-K | -2.61% | +0.97% | |
| Form 8-K Aquestive Therapeutics, For: Dec 19 | SEC filing · Form 8-K | -1.93% | +0.55% | |
| Form 8-K Aquestive Therapeutics, For: Dec 02 | SEC filing · Form 8-K | -3.46% | -7.68% | |
| Form 8-K Aquestive Therapeutics, For: Nov 01 | SEC filing · Form 8-K | -1.18% | +7.06% | |
| Form 8-K Aquestive Therapeutics, For: Nov 06 | SEC filing · Form 8-K | -1.39% | +1.20% | |
| Form 10-Q Aquestive Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -4.79% | -4.90% | |
| Form 8-K Aquestive Therapeutics, For: Nov 04 | SEC filing · Form 8-K | -4.79% | -4.90% | |
| Form 8-K Aquestive Therapeutics, For: Oct 25 | SEC filing · Form 8-K | -1.80% | -1.44% | |
| Form 8-K Aquestive Therapeutics, For: Oct 24 | SEC filing · Form 8-K | -0.19% | +1.67% | |
| Form 8-K Aquestive Therapeutics, For: Oct 16 | SEC filing · Form 8-K | -0.41% | +0.41% | |
| Form 8-K Aquestive Therapeutics, For: Sep 27 | SEC filing · Form 8-K | -1.75% | -7.99% | |
| Form 8-K Aquestive Therapeutics, For: Sep 09 | SEC filing · Form 8-K | +1.89% | +10.61% | |
| Form 8-K Aquestive Therapeutics, For: Aug 14 | SEC filing · Form 8-K | -3.50% | -3.50% | |
| Form 10-Q Aquestive Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.10% | -5.77% | |
| Form 8-K Aquestive Therapeutics, For: Aug 06 | SEC filing · Form 8-K | -1.10% | -5.77% | |
| Form 8-K Aquestive Therapeutics, For: Jul 25 | SEC filing · Form 8-K | -1.58% | -0.58% | |
| Form 8-K Aquestive Therapeutics, For: Jun 20 | SEC filing · Form 8-K | -2.73% | -5.08% | |
| Form 8-K Aquestive Therapeutics, For: Jun 06 | SEC filing · Form 8-K | -0.18% | -2.48% | |
| Form 8-K Aquestive Therapeutics, For: Jun 03 | SEC filing · Form 8-K | -0.18% | -2.48% | |
| Form 8-K Aquestive Therapeutics, For: May 07 | SEC filing · Form 8-K | -5.36% | -2.99% | |
| Form 10-Q Aquestive Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -5.36% | -2.99% | |
| Form 8-K Aquestive Therapeutics, For: May 07 | SEC filing · Form 8-K | -5.36% | -2.99% | |
| Form 8-K Aquestive Therapeutics, For: Apr 26 | SEC filing · Form 8-K | -7.00% | -3.24% | |
| Form ARS Aquestive Therapeutics, For: Dec 31 | SEC filing · Form ARS | -7.42% | -4.48% | |
| Form DEF 14A Aquestive Therapeutics, For: Jun 20 | SEC filing · Form DEF | -7.42% | -4.48% | |
| Form DEFA14A Aquestive Therapeutics, | SEC filing · Form DEFA14A | -7.42% | -4.48% | |
| Form EFFECT Aquestive Therapeutics, | SEC filing · Form EFFECT | -0.47% | -8.23% | |
| Form 8-K Aquestive Therapeutics, For: Apr 22 | SEC filing · Form 8-K | +0.23% | -2.28% | |
| Form S-3 Aquestive Therapeutics, | SEC filing · Form S-3 | -0.47% | -1.89% | |
| Form 8-K Aquestive Therapeutics, For: Apr 01 | SEC filing · Form 8-K | -1.18% | -2.82% | |
| Form 8-K Aquestive Therapeutics, For: Mar 19 | SEC filing · Form 8-K | +0.68% | -1.13% | |
| Form 8-K Aquestive Therapeutics, For: Mar 14 | SEC filing · Form 8-K | +1.85% | +12.99% | |
| Form 10-K Aquestive Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -8.74% | +22.68% | |
| Form 8-K Aquestive Therapeutics, For: Mar 05 | SEC filing · Form 8-K | -8.74% | +22.68% | |
| Form S-8 Aquestive Therapeutics, | SEC filing · Form S-8 | -1.10% | -2.93% | |
| Form 8-K Aquestive Therapeutics, For: Dec 07 | SEC filing · Form 8-K | — | -4.33% | |
| Form 8-K Aquestive Therapeutics, For: Dec 05 | SEC filing · Form 8-K | -2.80% | -4.40% | |
| Form 8-K Aquestive Therapeutics, For: Nov 08 | SEC filing · Form 8-K | +0.00% | +3.64% | |
| Form 10-Q Aquestive Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.60% | +3.01% | |
| Form 8-K Aquestive Therapeutics, For: Nov 06 | SEC filing · Form 8-K | -0.60% | +3.01% | |
| Form 8-K Aquestive Therapeutics, For: Nov 01 | SEC filing · Form 8-K | +2.19% | -7.10% |
Keep exploring
More AQST: earnings → · analyst actions → · AQST overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| INSYS THERAPEUTICS (INSY) | 731 | +0.00% | 50% |
| Myovant Sciences Ltd. Common Shares (MYOV) | 728 | 0.00% | 49% |
| RETROPHIN INC (RTRX) | 723 | +0.06% | 52% |
| IsoRay, Inc. (DE) (ISR) | 722 | -0.01% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.